hCMV

NeoVirTech is in the spotlight of Journal of Virology

Following several years of development of the ANCHOR technology, we are very proud to publish two bact-toback articles investigating real time infection of herpes viruses and adenoviruses. Both articles have been highligthed in the spotlight. They are in open acces, you can freely read them here:https://jvi.asm.org/content/92/18/e01266-18.

image com miguel

Generation of autofluorescent baculoviruses

NeoVirTech announces the generation of autofluorescent baculoviruses and the corresponding patent protection. Following collaboration with Dr Miguel Lopez-Ferber from the IMT Mines Alès, NeoVirTech has validated autofluorescent ANCHOR tagging of an insect virus for imaging and screening applications. Several autofluorescent baculoviruses have been generated allowing live cell tracking of virus genomes dynamics and replication, from single cells to organism. This achievement provides a new rapid and efficient tool to investigate bacculovirus biology, these viruses being used as gene transfer vectors, biopesticide or biomimetic of extremely dangerous pathogens. To know more about what the ANCHOR system can do, contact us at contact@neovirtech.com. To know more about IMT Mines Alès: http://www.mines-ales.fr/

ANCHOR VV

Generation of the first autofluorescent Vaccinia virus

Following collaboration with Transgene, a biotechnology company focused on discovering and developing targeted immunotherapies for the treatment of cancers and infectious diseases, we have validated the first poxvirus where the viral DNA is autofluorescent: the ANCHOR Vaccinia Virus (VV DNA in red). Treatments based on Vaccinia Viruses are among Transgene’s lead products. This virus can now be used to understand the behavior of oncolytic vectors and for screening applications in living cells. Microscopy data generated by autofluorescent viruses are a tremendous asset for communication/investor/media. More information: contact@neovirtech.com, communication@transgene.fr